Delivery Order SPE2DR25D1017-SPE2DR26F9BBX
- Not listed
- The Defense Logistics Agency awarded a $5,970.88 delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Oxcarbazepine ER 600 mg tablets (100-count units) with an ultimate completion date of December 5, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. The contract specifies performance at AmerisourceBergen's Conshohocken, Pennsylvania facility, the company's corporate headquarters and primary distribution center for...
- The U.S. Defense Department's Medical Supply Chain awarded a $4,923.54 delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Oxcarbazepine ER 600 mg tablets (100-count units). This firm fixed-price, non-set-aside contract is scheduled for ultimate completion by July 28, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order under a larger contract vehicle,...
- The Defense Logistics Agency awarded a $34.77K firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Oxcarbazepine ER 600 mg tablets (100-count units) with an ultimate completion date of May 13, 2025. This non-set-aside contract represents a competitive award to the pharmaceutical distributor, with performance taking place at the company's corporate office in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $16,858.83 delivery order to AmerisourceBergen Drug Corp on October 21, 2025, for the supply of Oxcarbazepine ER 300 mg tablets in quantities of 100 units. The contract represents a firm fixed price delivery order with an ultimate completion date of October 22, 2025, and was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and is a major...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Oxcarbazepine ER 600 mg tablets (100-count) on August 7, 2025, with a ceiling value of $12,813.16. This firm fixed price delivery order, which represents non-competitive procurement, is scheduled for completion by August 8, 2025, with performance taking place at the vendor's corporate office in Conshohocken, Pennsylvania. The contract carries no set-aside designation and was competitively awarded under the...
- The Defense Logistics Agency awarded a $2,043.54 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 8, 2025, for the supply of Oxcarbazepine ER 600 mg tablets in quantities of 100 units. The contract, which is non-set-aside and competitively awarded, has an ultimate completion date of July 9, 2025, with performance taking place at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a small-value pharmaceutical transaction...
- The Defense Logistics Agency awarded a $1,725.45 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Oxcarbazepine 300 mg/5 mL suspension (250 mL), an anticonvulsant medication used to treat neurological conditions. The delivery order, issued on December 8, 2025, with an ultimate completion date of December 9, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency (DLA) for Oxcarbazepine ER 600 mg tablets (100-count) with a ceiling value of $4,263.61. This competitively awarded, firm fixed-price contract has no set-aside designation and is scheduled for completion by September 30, 2025. The award represents a child delivery order issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,647.46 to AmerisourceBergen Drug Corp for the supply of 500 tablets of Oxcarbazepine 150 mg, an anticonvulsant medication commonly used to treat neurological conditions. This firm fixed-price delivery order, issued on September 22, 2025, with completion expected by September 23, 2025, represents a non-competitive set-aside purchase that leverages AmerisourceBergen's existing contract vehicle with DLA. The contractor will...
- The Defense Logistics Agency awarded a delivery order valued at $1,155.65 to AmerisourceBergen Drug Corp for Oxcarbazepine 300 mg/5 mL suspension (250 mL), an anticonvulsant medication commonly used in neurological treatment regimens. This firm fixed price delivery order, awarded on August 14, 2025, with an ultimate completion date of August 15, 2025, was competitively awarded without set-aside provisions. The work will be performed at AmerisourceBergen's corporate office location in...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F9BBXDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Oxcarbazepine ER 600 mg tablets (100-count units) with a ceiling value of $3,676.00. This firm fixed-price delivery order, which is set to be completed by December 10, 2025, represents a pediatric and adult neurological medication used primarily for seizure management and mood disorders. The award was competitively procured without any small business set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will fulfill this order from its Corporate Office location, leveraging its extensive capabilities as a major pharmaceutical distributor serving federal healthcare needs. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of medications and medical supplies to military healthcare systems worldwide. The DLA Troop Support Medical contract demonstrates the company's critical role in supporting the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems with specialty medications, generic drugs, vaccines, and related medical commodities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 12/8/25 |